ISSN: 0165-0327

Journal Home

Journal Guideline

Journal of Affective Disorders Q1 Unclaimed

Elsevier Netherlands

Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

Journal of Affective Disorders is a journal indexed in SJR in Psychiatry and Mental Health and Clinical Psychology with an H index of 205. It has an SJR impact factor of 1.791 and it has a best quartile of Q1. It is published in English. It has an SJR impact factor of 1.791.

Journal of Affective Disorders focuses its scope in these topics and keywords: depression, disorder, bipolar, depressive, major, patients, treatment, symptoms, health, suicide, ...

Type: Journal

Type of Copyright:

Languages: English

Open Access Policy:

Type of publications:

Publication frecuency: -

Categories: Clinical Psychology (Q1) Psychiatry and Mental Health (Q1)

Price

- €

Inmediate OA

NPD

Embargoed OA

- €

Non OA

Metrics

1.791

SJR Impact factor

205

H Index

1371

Total Docs (Last Year)

3254

Total Docs (3 years)

70405

Total Refs

19995

Total Cites (3 years)

3159

Citable Docs (3 years)

6.16

Cites/Doc (2 years)

51.35

Ref/Doc

Comments

No comments ... Be the first to comment!

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID *

* The email or ORCID field is only to validate the authenticity of the comment, the identity will not be public. .

Other journals with similar parameters

The Lancet Psychiatry Q1
Annual Review of Clinical Psychology Q1
JAMA Psychiatry Q1
Alzheimer's and Dementia Q1
Clinical Psychology Review Q1

Compare this journals

Aims and Scope

Best articles by citations

Is depression associated with immune activation?

A change in the density of [3H]flumazenil, but not [3H]muscimol binding, in Brodmann's Area 9 from subjects with bipolar disorder

Self-Esteem and Depression: ten year follow-up of mothers and offspring

Administration of antidepressants

The efficacy of imipramine and psychotherapy in early-onset chronic depression: a reanalysis of the National Institute of Mental Health Treatment of Depression Collaborative Research Program

Citalopram and Viloxazine in the treatment of depression by means of slow drop infusion

Major depressive disorder, depressive symptoms, and bilateral hearing loss in hispanic adults1An earlier version of this paper was presented at the 48th Annual Meeting of the Gerontological Society of America.1

Temperament and character inventory dimensions as a predictor of response to antidepressant treatment in major depression

Seasonality of manic depressive illness in Canada

Efficacy of intravenous citalopram compared with oral citalopram for severe depression

Depression in the carers of dementia sufferers: a comparison of the carers of patients suffering from dementia with Lewy Bodies and the carers of patients with Alzheimer's disease

Increased platelet 5-HT in patients with bipolar depression. Reply to Franke et al. [J. Affect. Disord. 52 (1999) 101-110]

SHOW MORE ARTICLES

Bilateral ECT and autobiographical memory of subjective experiences related to melancholia: A pilot study

The validity of diagnosis of melancholic depression according to different diagnostic systems1This study was presented as a poster at the `World Psychiatric Congress', Madrid, Spain, 1996.1

Characteristics of patients with otherwise typical winter depression, but with incomplete summer remission

Acting out' and 'acting in' behavioural stress responses: the relevance of anxiety and personality style

Possible effect of gender and season on the length of hospitalisation in unipolar major depressives

Testosterone replacement therapy for hypogonadal men with SSRI-refractory depression

A definite and a semidefinite questionnaire version of the Hamilton/melancholia (HDS/MES) scale

Outcome for adjustment disorder with depressed mood: comparison with other mood disorders

Seasonal changes in 24-h patterns of suicide rates: a study on train suicides in The Netherlands

Functional cerebral asymmetry in affective disorders: new facts contributed by transcranial magnetic stimulation

Open maintenance treatment of bipolar disorder spectrum patients who responded to gabapentin augmentation in the acute phase of treatment

Familial rates of affective and substance use disorders in patients with first-episode mania